Get started
Author

Andreas–Antonios Roussakis

Observed names: A Roussakis, A. A. Roussakis, A. ROUSSAKIS, A. Roussakis, A.A. Roussakis, AA Roussakis, Andreas A Roussakis, Andreas A. Roussakis, Andreas Antonios Roussakis, Andreas Antonios-Roussakis, Andreas Roussakis, Andreas-Antonios Roussakis, Roussakis, A, Roussakis, A. A., Roussakis, AA, Roussakis, Andreas Antonios
Observed institutions: Imperial College Healthcare NHS Trust, King's College London, Hammersmith Hospital, Hygeia Hospital, King's College Hospital, Imperial College London
ORCID: 0000-0001-5748-6978
Observed ORCID: 0000-0001-5748-6978
OpenAlex ID: A5068228767
Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease
2016 · Michal Rolinski, Ludovica Griffanti, et al. · Brain · 136
PDF
Serotonin-to-dopamine transporter ratios in Parkinson disease
2016 · Andreas-Antonios Roussakis, Marios Politis, et al. · Neurology · 79
Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system
2019 · Antonio Martín-Bastida, Nicholas P Lao-Kaim, et al. · Brain · 73
PDF
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross‐sectional study of iron‐related magnetic resonance imaging susceptibility
2016 · A. Martin‐Bastida, N. P. Lao‐Kaim, et al. · European Journal of Neurology · 67
11C‐PE2I and 18F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study
2017 · Weihua Li, Nick P. Lao‐Kaim, et al. · Movement Disorders · 63
Levodopa-induced Dyskinesia in Parkinson's: a Longitudinal Pet Study
2016 · Andreas-Antonios Roussakis, Nicholas Lao-Kaim, et al. · Journal of Neurology Neurosurgery & Psychiatry · 46
Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson’s disease
2020 · Weihua Li, Nick P. Lao-Kaim, et al. · NeuroImage Clinical · 42
PDF
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single‐arm efficacy
2021 · Martin R. Wilkins, Mikel A. Mckie, et al. · Pulmonary Circulation · 32
PDF
Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's disease
2020 · Eleanor Porter, Andreas-Antonios Roussakis, et al. · Parkinsonism & Related Disorders · 28
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study
2025 · Alexander M. K. Rothman, Sofia S. Villar, et al. · American Journal of Respiratory and Critical Care Medicine · 27
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease
2025 · Roger A. Barker, Nicholas P. Lao-Kaim, et al. · Nature Biotechnology · 26
PDF
Biexponential T2 Relaxation Time Analysis of the Brain
2002 · N. PAPANIKOLAOU, V. MANIATIS, et al. · Investigative Radiology · 26
A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
2023 · Andreas-Antonios Roussakis, Marta Gennaro, et al. · Brain Communications · 24
PDF
PET Imaging in Huntington’s Disease
2015 · Andreas-Antonios Roussakis, Paola Piccini · Journal of Huntington s Disease · 22
PDF
Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease
2018 · Andreas-Antonios Roussakis, Paola Piccini · International review of neurobiology · 21
Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
2019 · Andreas–Antonios Roussakis, Nicholas P. Lao–Kaim, et al. · Current Neurology and Neuroscience Reports · 20
PDF
Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with 11C-BU99008 PET
2022 · Mohamed A Mohamed, Zhou Zeng, et al. · Brain Communications · 19
PDF
Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes
2020 · Zhou Zeng, Andreas-Antonios Roussakis, et al. · Neurobiology of Aging · 18
Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson’s disease
2020 · Peter Owen Jenkins, Andreas-Antonios Roussakis, et al. · Journal of Neurology Neurosurgery & Psychiatry · 17
PDF
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
2020 · Andreas-Antonios Roussakis, Zhou Zeng, et al. · Journal of Neurology · 11
PDF
Longitudinal changes in movement-related functional MRI activity in Parkinson's disease patients
2021 · Naomi Hannaway, Nicholas P. Lao-Kaim, et al. · Parkinsonism & Related Disorders · 8
PDF
Dopamine Transporter Density in de novo Parkinson's Disease Does Not Relate to the Development of Levodopa-Induced Dyskinesias.
2019 · Andreas-Antonios Roussakis, Marta Gennaro, et al. · PubMed · 7
Diagnostic Value of Swallow Tail Sign at Brain MRI in Patients with Clinically Uncertain Parkinsonian Syndrome
2025 · Yue Xing, Saadnah Naidu, et al. · Radiology · 6
Dissociable effects of age and Parkinson’s disease on instruction-based learning
2021 · Beth L Parkin, Richard E Daws, et al. · Brain Communications · 3
PDF
Benefits of a 12-week psychotherapy course for people with Parkinson’s disease: a service improvement project
2025 · Andreas-Antonios Roussakis, Rima Hawkins, et al. · Journal of Neurology · 2
PDF
Works count: 49
Citation count: 834
H-index: 18
I10-index: 20
Year
Topic
Type